LEAH BROYLES: Open Payments
NPI 1750163960 · MARION, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $212 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| ABBVIE INC. | 2 | $43 |
| Lilly USA, LLC | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 2 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: AIRSUPRA, VRAYLAR, MOUNJARO, INJECTAFER, Dexcom G6 Transmitter, Auvelity, VOQUEZNA, PAXLOVID.
Industry payments across IN — which companies pay providers there.
